![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C12N 7/00 | (2006.01) |
C12N2710/16621 | (2013.01) | ||
C12N2710/16633 | (2013.01) | ||
C12N 7/00 | (2013.01) | ||
A61P 35/00 | (2018.01) |
(11) | Patento numeris | 3400290 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17700384.5 |
Europos patento paraiškos padavimo data | 2017-01-09 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-11-14 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-04-05 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/GB2017/050037 |
Data | 2017-01-09 |
(87) | Numeris | WO 2017/118865 |
Data | 2017-07-13 |
(30) | Numeris | Data | Šalis |
201600380 | 2016-01-08 | GB | |
201600381 | 2016-01-08 | GB | |
201600382 | 2016-01-08 | GB |
(72) |
COFFIN, Robert , GB
|
(73) |
Replimune Limited ,
69 Innovation Centre
Milton Park, Oxford, Oxfordshire OX14 4RQ,
GB
|
(54) | ONCOLYTIC VIRUS STRAIN |
ONCOLYTIC VIRUS STRAIN |